Anthropic reveals six Claude drug-development partnerships and its acquisition of Mithril Medicine; the work is mostly preclinical, with Mithril human trials possible from late 2028 if candidates hold up.

Figure 11 and its caption from Mithril’s October 26, 2026 technical report, not peer reviewed: antibody-treated mouse force and grip-strength measurements, not human treatment results.

Published 27 Oct 2026 · 22:31 UTC

Anthropic ↗ · Source dated 27 Oct 2026

Browse all Live updates · Read Features